The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features.
Hematology Laboratory, University Hospital, Nantes, France marion.eveillard@chu-nantes.fr.
Marion
M
Eveillard
Hematology Clinic, University Hospital, Nantes, France.
Jacques
J
Delaunay
Hematology Laboratory, University Hospital, Nantes, France Cytogenetics, CHU Québec Hôpital Saint Sacrement, Québec, Canada.
Steven
S
Richebourg
Hematology Laboratory, University Hospital, Nantes, France.
Laurence
L
Lodé
Hematology Laboratory, University Hospital, Nantes, France.
Richard
R
Garand
Hematology Laboratory, University Hospital, Nantes, France.
Soraya
S
Wuillème
Hematologic Genetics, Clinique Universitaire Saint Luc, UCL, Brussels, Belgium.
François
F
Duhoux
Hematologic Genetics, Clinique Universitaire Saint Luc, UCL, Brussels, Belgium.
Hélène
H
Antoine-Poirel
Hematology Laboratory, University Hospital, Nantes, France.
Catherine
C
Godon
Hematology Laboratory, University Hospital, Nantes, France.
Marie C
MC
Béné
D004268:DNA-Binding Proteins / Q000235:genetics*; D015870:Gene Expression; D015321:Gene Rearrangement; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics* / Q000401:mortality*; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics*; D011519:Proto-Oncogenes / Q000235:genetics*; D014157:Transcription Factors / Q000235:genetics*
D004268:DNA-Binding Proteins; D014157:Transcription Factors; D051788:Myeloid-Lymphoid Leukemia Protein
EVI1; PRDM16; acute myeloblastic leukemia